In vitro cultured rat islets express genes that both prevent and promote angiogenesis

Journal of the Pancreas

Volumn 5, Issue 2, 2004, Pages 81-91

  Tillmar, Linda ^a   Welsh, Nils ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Angiopoietins; Anoxia; Gene expression; Platelet factor 4; Receptors, TIE; Serpins; Thrombospondins; Transplantation; Vascular endothelial growth factors

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; MESSENGER RNA; PROTEIN TYROSINE KINASE; TYROSINE KINASE WITH IMMUNOGLOBULIN AND EPIDERMAL GROWTH FACTOR HOMOLOGY DOMAINS 1; UNCLASSIFIED DRUG; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; ANGIOGENIC PROTEIN;

ACCURACY; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CONTROLLED STUDY; GENE EXPRESSION; GRAFT SURVIVAL; HYPOXEMIA; IN VITRO STUDY; ISOLATED PANCREAS ISLET; NONHUMAN; ORGAN CULTURE; PANCREAS BLOOD FLOW; PANCREAS TRANSPLANTATION; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; REVASCULARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL CULTURE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PANCREAS ISLET; SPRAGUE DAWLEY RAT;

ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ANIMALS; CELLS, CULTURED; GENE EXPRESSION PROFILING; ISLETS OF LANGERHANS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 1542349052     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets. Diabetologia 2002; 45:749-63. [PMID 12107718]
2. Carlsson PO, Palm F, Andersson A, Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 2001; 50:489-95. [PMID 11246867]
3. Carlsson PO, Palm F, Andersson A, Liss P. Chronically decreased oxygen tension in rat pancreatic islets transplanted under the kidney capsule. Transplantation 2000; 69:761-6. [PMID 10755523]
4. Carlsson PO, Kiuru A, Nordin A, Olsson R, Lin JM, Bergsten P, et al. Microdialysis measurements demonstrate a shift to nonoxidative glucose metabolism in rat pancreatic islets transplanted beneath the renal capsule. Surgery 2002; 132:487-494. [PMID 12324763]
5. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 1999; 237:1-30. [PMID 9893343]
6. Christofori G, Naik P, Hanahan D. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol Endocrinol 1995; 9:1760-70. [PMID 8614412]
7. Gorden DL, Mandriota SJ, Montesano R, Orci L, Pepper MS. Vascular endothelial growth factor is increased in devascularized rat islets of Langerhans in vitro. Transplantation 1997; 63:436-43. [PMID 9039936]
8. Vasir B, Aiello LP, Yoon KH, Quickel RR, Bonner-Weir S, Weir GC. Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes 1998; 47:1894-903. [PMID 9836521]
9. Vasir B, Jonas JC, Steil GM, Hollister-Lock J, Hasenkamp W, Sharma A, et al. Gene expression of VEGF and its receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets. Transplantation 2001; 71:924-35. [PMID 11349728]
10. Carlsson PO, Mattsson G. Oxygen tension and blood flow in relation to revascularization in transplanted adult and fetal rat pancreatic islets. Cell Transplant 2002; 11:813-820. [PMID 12588114]
11. Schramm R, Yamauchi J, Vollmar B, Vajkoczy P, Menger MD. Blockade of in vivo VEGF-KDR/flk-1 signaling does not affect revascularization of freely transplanted pancreatic islets. Transplantation 2003; 75:239-42. [PMID 12548132]
12. Vasir B, Reitz P, Xu G, Sharma A, Bonner-Weir S, Weir GC. Effects of diabetes and hypoxia on gene markers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-alpha, TGF-beta, bFGF and Vimentin) in cultured and transplanted rat islets. Diabetologia 2000; 43:763-72. [PMID 10907122]
13. Vajkoczy P, Olofsson AM, Lehr HA, Leiderer R, Hammersen F, Arfors KE, Menger MD. Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. Am J Pathol 1995; 146:1397-405. [PMID 7539980]
14. Linn T, Schneider K, Hammes HP, Preissner KT, Brandhorst H, Morgenstern E, et al. Angiogenic capacity of endothelial cells in islets of Langerhans. FASEB J 2003; 17:881-3. [PMID 12670881]
15. Andersson A. Isolated mouse pancreatic islets in culture: effects of serum and different culture media on the insulin production of the islets. Diabetologia 1978; 14:397-404. [PMID 352776]
16. Tillmar L, Carlsson C, Welsh N. Control of insulin mRNA stability in rat pancreatic islets. Regulatory role of a 3′-untranslated region pyrimidine-rich sequence. J Biol Chem 2002; 277:1099-106. [PMID 11696543]
17. Tillmar L, Welsh N. Hypoxia may increase rat insulin mRNA levels by promoting binding of the polypyrimidine tract-binding protein (PTB) to the pyrimidine-rich insulin mRNA 3′-untranslated region. Mol Med 2002; 8:263-272. [PMID 12359957]
18. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16:4604-13. [PMID 8756616]
19. Liu LX, Lu H, Luo Y, Date T, Belanger AJ, Vincent KA, et al. Stabilization of vascular endothelial growth factor mRNA by hypoxia- inducible factor 1. Biochem Biophys Res Commun 2002; 291:908-914. [PMID 11866451]
20. Moritz W, Meier F, Stroka DM, Giuliani M, Kugelmeier P, Nett PC, et al. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. FASEB J 2002; 16:745-7. [PMID 11923216]
21. Lammert E, Gu G, McLaughlin M, Brown D, Brekken R, Murtaugh LC, et al. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 2003; 13:1070-4. [PMID 12814555]
22. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994; 8:1897-909. [PMID 7958865]
23. Partanen J, Armstrong E, Makela TP, Korhonen J, Sandberg M, Renkonen R, et al. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 1992; 12:1698-1707. [PMID 1312667]
24. Iwama A, Hamaguchi I, Hashiyama M, Murayama Y, Yasunaga K, Suda T. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Commun 1993; 195:301-9. [PMID 8395828]
25. Maisonpierre PC, Goldfarb M, Yancopoulos GD, Gao G. Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene 1993; 8:1631-7. [PMID 7684830]
26. Sato TN, Qin Y, Kozak CA, Audus KL. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci U S A 1993; 90:9355-8. [PMID 8415706]
27. Schnurch H, Risau W. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 1993; 119:957-68. [PMID 8187650]
28. Ziegler SF, Bird TA, Schneringer JA, Schooley KA, Baum PR. Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene 1993; 8:663-70. [PMID 8382358]
29. Tallquist MD, Soriano P, Klinghoffer RA. Growth factor signaling pathways in vascular development. Oncogene 1999; 18:7917-32. [PMID 10630644]
30. Loughna S, Sato TN. Angiopoietin and Tie signaling pathways in vascular development. Matrix Biol 2001; 20:319-25. [PMID 11566266]
31. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87:1161-9. [PMID 8980223]
32. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55-60. [PMID 9204896]
33. Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999; 18:5356-62. [PMID 10498889]
34. Kampfer H, Pfeilschifter J, Frank S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 2001; 81:361-73. [PMID 11310829]
35. Kwak HJ, Lee SJ, Lee YH, Ryu CH, Koh KN, Choi HY, et al. Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. Circulation 2000; 101:2317-24. [PMID 10811601]
36. Tsiamis AC, Morris PN, Marron MB, Brindle NP. Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex. Microvasc Res 2002; 63:149-58. [PMID 11866538]
37. Marron MB, Hughes DP, Edge MD, Forder CL, Brindle NP. Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2. J Biol Chem 2000; 275:39741-6. [PMID 10995770]
38. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 1998; 273:18514-21. [PMID 9660821]
39. Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000; 7:165-97. [PMID 11021964]
40. Sato Y, Rifkin DB. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 1988; 107:1199-205. [PMID 3417781]
41. Stagner JI, Samols E. Induction of angiogenesis by growth factors: relevance to pancreatic islet transplantation. EXS 1992; 61:381-5. [PMID 1377558]
42. Hayek A, Lopez AD, Beattie GM. Angiogenic peptides in pancreatic islet transplantation to diabetic rats. Transplantation 1990; 50:931-3. [PMID 2256164]
43. Gu Y, Tabata Y, Kawakami Y, Balamurugan AN, Hori H, Nagata N, et al. Development of a new method to induce angiogenesis at subcutaneous site of streptozotocin-induced diabetic rats for islet transplantation. Cell Transplant 2001; 10:453-7. [PMID 11549071]
44. Kawakami Y, Iwata H, Gu YJ, Miyamoto M, Murakami Y, Balamurugan AN, et al. Successful subcutaneous pancreatic islet transplantation using an angiogenic growth factor-releasing device. Pancreas 2001; 23:375-81. [PMID 11668206]
45. Mattsson G, Carlsson PO, Olausson K, Jansson L. Histological markers for endothelial cells in endogenous and transplanted rodent pancreatic islets. Pancreatology 2002; 2:155-62. [PMID 12123096]
46. Mattsson G, Jansson L, Carlsson PO. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 2002; 51:1362-6. [PMID 11978631]
47. Mattsson G, Jansson L, Nordin A, Carlsson PO. Impaired revascularization of transplanted mouse pancreatic islets is chronic and glucose-independent. Transplantation 2003; 75:736-9. [PMID 12640320]
48. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999; 79:1283-316. [PMID 10508235]
49. Edelberg JM, Aird WC, Wu W, Rayburn H, Mamuya WS, Mercola M, et al. PDGF mediates cardiac microvascular communication. J Clin Invest 1998; 102:837-43. [PMID 9710453]
50. Affleck DG, Bull DA, Bailey SH, Albanil A, Connors R, Stringham JC, et al. PDGF(BB) increases myocardial production of VEGF: shift in VEGF mRNA splice variants after direct injection of bFGF, PDGF(BB), and PDGF(AB). J Surg Res 2002; 107:203-9. [PMID 12429176]
51. De Marchis F, Ribatti D, Giampietri C, Lentini A, Faraone D, Scoccianti M, et al. Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor. Blood 2002; 99:2045-53. [PMID 11877278]
52. Souttou B, Raulais D, Vigny M. Pleiotrophin induces angiogenesis: involvement of the phosphoinositide- 3 kinase but not the nitric oxide synthase pathways. J Cell Physiol 2001; 187:59-64. [PMID 11241349]
53. Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY. Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 2002; 397:162-71. [PMID 11795867]
54. Yeh HJ, He YY, Xu J, Hsu CY, Deuel TF. Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury. J Neurosci 1998; 18:3699-707. [PMID 9570800]
55. Valdimarsdottir G, Goumans MJ, Rosendahl A, Brugman M, Itoh S, Lebrin F, et al. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 2002; 106:2263-70. [PMID 12390958]
56. Yang X, Castilla LH, Xu X, Li C, Gotay J, Weinstein M, et al. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 1999; 126:1571-80. [PMID 10079220]
57. Carmeliet P, Collen D. Transgenic mouse models in angiogenesis and cardiovascular disease. J Pathol 2000; 190:387-405. [PMID 10685072]
58. Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reuning U, et al. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 1997; 78:285-96. [PMID 9198168]
59. Chader GJ. PEDF: Raising both hopes and questions in controlling angiogenesis. Proc Natl Acad Sci U S A 2001; 98:2122-4. [PMID 11226201]
60. Bouck N. PEDF: anti-angiogenic guardian of ocular function. Trends Mol Med 2002; 8:330-4. [PMID 12114112]
61. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999; 285:245-8. [PMID 10398599]
62. Volpert OV, Zaichuk T, Zhou W, Reiher F, Ferguson TA, Stuart PM, et al. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 2002; 8:349-57. [PMID 11927940]
63. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 1990; 247:77-9. [PMID 1688470]
64. Gupta SK, Singh JP. Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression. J Cell Biol 1994; 127:1121-7. [PMID 7962072]
65. Sato Y, Abe M, Takaki R. Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells. Biochem Biophys Res Commun 1990; 172:595-600. [PMID 2173572]
66. Gengrinovitch S, Greenberg SM, Cohen T, Gitay-Goren H, Rockwell P, Maione TE, et al. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms. J Biol Chem 1995; 270:15059-65. [PMID 7797488]
67. Perollet C, Han ZC, Savona C, Caen JP, Bikfalvi A. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood 1998; 91:3289-99. [PMID 9558385]
68. Adams JC. Thrombospondins: multifunctional regulators of cell interactions. Annu Rev Cell Dev Biol 2001; 17:25-51. [PMID 11687483]
69. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A 1990; 87:6624-8. [PMID 1697685]
70. Volpert OV, Tolsma SS, Pellerin S, Feige JJ, Chen H, Mosher DF, et al. Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 1995; 217:326-32. [PMID 8526929]
71. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, et al. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 1998; 101:982-92. [PMID 9486968]
72. Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, et al. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 1998; 140:419-30. [PMID 9442117]
73. de Fraipont F, Nicholson AC, Feige JJ, Van Meir EG. Thrombospondins and tumor angiogenesis. Trends Mol Med 2001; 7:401-7. [PMID 11530335]
74. Qabar AN, Bullock J, Matej L, Polverini P. Expression and characterization of novel thrombospondin 1 type I repeat fusion proteins. Biochem J 2000; 346 Pt 1:147-53. [PMID 10657251]